Insiders · Profile

Koya Keizo

Sr. VP, Drug Development at MADRIGAL PHARMACEUTICALS. Filing since 24 Aug 2009. CIK 0001325718

Company
Date
Role
Action
Shares
Amount
Of holding
1 Mar 2012
Sr. VP, Drug Development
Sold, plan not stated
6,844
$32.19K
34.5%
25 Apr 2011
Sr. VP, Drug Development
Sold, plan not stated
10,000
$60.00K
33.5%
20 Apr 2011
Sr. VP, Drug Development
Sold, plan not stated
10,000
$56.00K
25.1%
1 Mar 2011
Sr. VP, Drug Development
Sold, plan not stated
18,270
$95.55K
35.6%
24 Aug 2009
Sr. VP, Drug Development
Bought
10,000
$28.43K
30.3%
5 decisions on file.